RIONDINO, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 15.038
AS - Asia 2.003
EU - Europa 1.564
SA - Sud America 301
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 18.943
Nazione #
US - Stati Uniti d'America 14.982
SG - Singapore 1.000
CN - Cina 373
IT - Italia 301
BR - Brasile 253
RU - Federazione Russa 228
HK - Hong Kong 179
UA - Ucraina 173
IE - Irlanda 164
DE - Germania 161
VN - Vietnam 157
FR - Francia 153
PL - Polonia 113
GB - Regno Unito 87
FI - Finlandia 76
KR - Corea 68
JP - Giappone 61
IN - India 54
CA - Canada 32
NL - Olanda 32
ID - Indonesia 19
AR - Argentina 18
BD - Bangladesh 16
ES - Italia 16
AT - Austria 13
MX - Messico 13
EC - Ecuador 11
TR - Turchia 11
SE - Svezia 10
IQ - Iraq 9
MA - Marocco 9
PK - Pakistan 9
SA - Arabia Saudita 9
BE - Belgio 8
PH - Filippine 8
CH - Svizzera 6
CZ - Repubblica Ceca 6
EG - Egitto 6
MY - Malesia 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
CO - Colombia 5
EU - Europa 5
ZA - Sudafrica 4
AL - Albania 3
AU - Australia 3
CR - Costa Rica 3
LT - Lituania 3
PT - Portogallo 3
PY - Paraguay 3
TH - Thailandia 3
UZ - Uzbekistan 3
GA - Gabon 2
HN - Honduras 2
IR - Iran 2
NP - Nepal 2
OM - Oman 2
QA - Qatar 2
RO - Romania 2
SV - El Salvador 2
TW - Taiwan 2
VE - Venezuela 2
AO - Angola 1
BG - Bulgaria 1
BO - Bolivia 1
BZ - Belize 1
CG - Congo 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GD - Grenada 1
GT - Guatemala 1
GY - Guiana 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
MT - Malta 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UY - Uruguay 1
Totale 18.943
Città #
Woodbridge 4.029
Wilmington 3.610
Houston 3.482
Singapore 572
Fairfield 439
Ashburn 323
Chandler 286
Ann Arbor 275
Seattle 216
Cambridge 200
San Jose 193
Hong Kong 175
Beijing 156
Dublin 143
Jacksonville 142
New York 107
Kraków 105
Medford 103
Rome 100
The Dalles 92
Santa Clara 85
Council Bluffs 84
Los Angeles 66
Dallas 63
Dearborn 61
Tokyo 59
San Diego 55
Ho Chi Minh City 50
Lawrence 48
Buffalo 46
Lauterbourg 45
Menlo Park 35
Hanoi 32
Moscow 31
Orem 31
Helsinki 25
Zhengzhou 24
Engelhard 20
Milan 20
Nuremberg 20
São Paulo 19
Chicago 18
London 18
Chennai 15
Jakarta 15
Lappeenranta 13
Salt Lake City 13
Frankfurt am Main 12
Manchester 12
Boardman 11
Nanjing 11
Redondo Beach 11
Detroit 10
Mumbai 10
Montreal 9
Munich 9
North Bergen 9
Brussels 8
Creede 8
Da Nang 8
Denver 8
Shanghai 8
Brooklyn 7
Guangzhou 7
Norwalk 7
Quito 7
Rio de Janeiro 7
Verona 7
Warsaw 7
Amsterdam 6
Ankara 6
Boston 6
Brno 6
Kunming 6
Naples 6
Roubaix 6
San Francisco 6
Stockholm 6
Toronto 6
Turin 6
Belo Horizonte 5
Charlotte 5
Columbus 5
Falls Church 5
Hải Dương 5
Miami 5
Monte Vista 5
Mountain View 5
Poplar 5
Redwood City 5
Tampa 5
Vienna 5
Atlanta 4
Barcelona 4
Biên Hòa 4
Cairo 4
Campinas 4
Casablanca 4
Curitiba 4
Fort Worth 4
Totale 16.110
Nome #
Sample PREanalytical Code for labeling of biospecimens: an analysis of specimen labeling protocols 493
Anti-angiogenic drugs, vascular toxicity and thromboembolism in solid cancer 493
Ketogenic diet and other dietary intervention strategies in the treatment of cancer 463
Predictive value of high-sensitive D-dimer determination for chemotherapy-associated venous thromboembolism in gastrointestinal cancer patients 462
Biological and predictive role of ERCC1 polymorphisms in cancer 460
Functional impairment of activated protein C in breast cancer - relationship to survival outcomes 459
RISK: A random optimization interactive system based on kernel learning for predicting breast cancer disease progression 458
Clinical models and biochemical predictors of VTE in lung cancer 457
Risk assessment for venous thromboembolism in chemotherapy treated ambulatory cancer patients: a machine learning approach 454
Early changes of a novel APC-dependent thrombin generation assay during chemotherapy independently predict venous thromboembolism in cancer patients--a pilot study 451
Prognostic value of glycated hemoglobin in colorectal cancer 450
Venous thromboembolism risk prediction in ambulatory cancer patients: Clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio 449
Type 2 diabetes and breast cancer: The interplay between impaired glucose metabolism and oxidant stress 448
An activated protein C-dependent thrombin generation assay predicts chemotherapy-associated venous thromboembolism in cancer patients 447
Oxidant stress as a major determinant of platelet activation in invasive breast cancer 447
Obesity and colorectal cancer: role of adipokines in tumor initiation and progression 446
RFID as a new ICT tool to monitor specimen life cycle and quality control in a biobank 446
Novel high-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in intermediate risk lung cancer patients 440
Association between increased tumor necrosis factor alpha levels and acquired activated protein C resistance in patients with metastatic colorectal cancer 426
Pretreatment Insulin Levels as a Prognostic Factor for Breast Cancer Progression 426
Determinants of homocysteine levels in colorectal and breast cancer patients 422
VEGF and VTE risk in cancer patients-letter 417
VEGF gene promoter polymorphisms and risk of VTE in chemotherapytreated cancer patients 415
Impact of chemotherapy on venous thromboembolism: comment to: regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study 410
Ensuring Sample Quality for Biomarker Discovery Studies - Use of ICT Tools to Trace Biosample Life-cycle 408
Evaluation of mean platelet volume as a predictive marker for cancer-associated venous thromboembolism during chemotherapy 402
Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin 402
Impact of VEGF gene polymorphisms in elderly cancer patients: Clinical outcome and toxicity 396
Predictive value of high-density lipoprotein (HDL)-cholesterol for cancer-associated venous thromboembolism during chemotherapy 393
Estimated glomerular filtration rate is an easy predictor of venous thromboembolism in cancer patients undergoing platinum-based chemotherapy 389
Insulin resistance as a predictor of venous thromboembolism in breast cancer 378
Prognostic significance of serum adipokine levels in colorectal cancer patients 377
Validation of a machine learning approach for venous thromboembolism risk prediction in oncology 374
Impact of chemotherapy on activated protein C-dependent thrombin generation--association with VTE occurrence 372
Breast Cancer Prognosis Using a Machine Learning Approach 369
Plasma plasminogen activator inhibitor-1 (PAI-1) levels in breast cancer - relationship with clinical outcome 344
Clinical significance of glycemic parameters on venous thromboembolism risk preDiction in gastrointestinal cancer 323
SPRECware: software tools for Standard PREanalytical Code (SPREC) labeling - effective exchange and search of stored biospecimens 316
Precision medicine in the ageing world: The role of biospecimen sciences 300
Predicting VTE in cancer patients: Candidate biomarkers and risk assessment models 237
Artificial Intelligence Predictive Models of Response to Cytotoxic Chemotherapy Alone or Combined to Targeted Therapy for Metastatic Colorectal Cancer Patients: A Systematic Review and Meta-Analysis 128
Clinical utility of plasma KRAS, NRAS and BRAF mutational analysis with real time PCR in metastatic colorectal cancer patients -The importance of tissue/plasma discordant cases 123
NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic Review of Case Reports and Case Series 122
Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events? 121
Activity of ALK inhibitors in renal cancer with ALK alterations: a systematic review 120
Irinotecan or oxaliplatin: which is the first move for the mate? 117
Extracellular volume measured by whole body CT scans predicts chronic cardiotoxicity in breast cancer patients treated with neoadjuvant therapies based on anthracyclines: a retrospective study 114
Venous Thromboembolism in Cancer Patients on Simultaneous and Palliative Care 111
Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy? 107
KRAS and BRAF Mutations in Stage II/III Colon Cancer: A Systematic Review and Meta-Analysis 106
Effects of rosuvastatin on platelet inhibition by clopidogrel in cardiovascular patients 96
Irinotecan- vs. Oxaliplatin-Based Doublets in KRASG12C-Mutated Metastatic Colorectal Cancer-A Multicentre Propensity-Score-Matched Retrospective Analysis 92
HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling 90
Untailored vs. Gender- and Body-Mass-Index-Tailored Skeletal Muscle Mass Index (SMI) to Assess Sarcopenia in Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) 86
MiRNAs and circRNAs for the Diagnosis of Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients: A Narrative Review 85
Concordance of blood-based and normal tissue-based dihydropyrimidine dehydrogenase (DPYD) genotyping 79
Case report: Metastatic melanoma derived from a somatic-type malignant transformation of a mediastinal teratoma treated with immune checkpoint inhibitors 78
Immune Response in Vitamin D Deficient Metastatic Colorectal Cancer Patients: A Player That Should Be Considered for Targeted Vitamin D Supplementation 78
Nutritional index for immune-checkpoint inhibitor in patients with metastatic gastro-esophageal junction/gastric cancer 76
Gender differences in cancer-associated venous thromboembolism 75
Evaluating Explainable Machine Learning Models for Clinicians 74
The Role of Histology-Agnostic Drugs in the Treatment of Metastatic Castration-Resistant Prostate Cancer 73
Antibody-Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives 73
Biospecimen Digital Twins: Moving from a "High Quality" to a "Fit-for-Purpose" Concept in the Era of Omics Sciences 66
Drug recommendation ranking for personalized medicine using outcomes of retrospective cancer patients 60
Obesity and common pathways of cancer and cardiovascular disease 59
Enhanced TNF alpha and oxidative stress in patients with heart failure: effect of TNF alpha on platelet O2- production 57
PD-L1 thresholds predict efficacy of immune checkpoint inhibition in first-line treatment of advanced gastroesophageal adenocarcinoma. A systematic review and meta-analysis of seven phase III randomized trials 48
Platelet function in health and disease: from molecular mechanisms, redox considerations to novel therapeutic opportunities 48
Factor seven activating protease activity levels in women with recurrent pregnancy loss 45
Obesity-driven inflammation and colorectal cancer 44
The Use of Artificial Intelligence in Predicting Chemotherapy-Induced Toxicities in Metastatic Colorectal Cancer: A Data-Driven Approach for Personalized Oncology 20
Totale 19.190
Categoria #
all - tutte 48.515
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.515


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021172 0 0 0 0 0 0 0 0 0 56 90 26
2021/2022627 26 49 11 10 19 30 56 107 36 128 32 123
2022/2023713 71 63 11 82 95 160 48 66 56 7 29 25
2023/2024334 34 10 23 23 23 94 42 12 8 6 6 53
2024/20251.603 44 361 146 108 43 88 134 87 185 188 138 81
2025/20262.474 193 126 367 198 267 90 357 317 337 222 0 0
Totale 19.190